Attachment A - Line Items.xlsx
XLSX spreadsheet 221 KB Posted
- Solicitation number
- 36C25725Q0901
About this file
The file is an Attachment A - Line Items spreadsheet detailing a comprehensive laboratory testing services contract for the VA North Texas Healthcare System. The document lists 17 line items for specialized pathology and laboratory testing services, including tissue biopsy consultations, surgical pathology examinations, transplant biopsies, necropsies, immunohistochemistry (IHC) stains, in-situ hybridization, morphometric analysis, genetic mutation testing, flow cytometry, and cytogenetic/chromosome analyses. The line items specify detailed quantities for each service, ranging from 5 to 1,800 individual tests, with specific CPT codes and options for various specialized antibody and probe staining procedures.
The related federal contract opportunity is a pre-solicitation for the VA Veterans Health Administration Network Contracting Office 17, seeking a reference laboratory testing services contractor. The solicitation requires a vendor to provide laboratory testing services for patient specimens that VA North Texas Healthcare System cannot perform on-site, with mandatory compliance with VHA Handbook 1106.01 and 42 CFR Part 493. The contractor must hold a Centers for Medicare & Medicaid Services (CMS) accreditation and meet Clinical Laboratory Improvement Amendments (CLIA) requirements. The sources sought notice is for informational purposes to determine if sufficient small business concerns can perform the described work.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| SOW FY25 Referral Lab.pdf | ||
| 36C25725Q0901.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| ITEM NUMBER | SLIN | DESCRIPTION | QUANTITY | UNIT OF MEASURE | PROVIDE TESTING? (Y/N) | SUBCONTRACTED? (Y/N) | SUBCONTRACTOR NAME | LOCATION OF TESTING | CLIA NUMBER | |
| 0001 | Tissue Biopsy Consultation with or without slide processing | |||||||||
| CPT: 88321, 88332, 88323 | 1800 | EA | ||||||||
| 0002 | Level IV Surgical Pathology Examination | |||||||||
| CPT: 88305 | 10 | EA | ||||||||
| 0003 | Transplant Biopsy with Complement 4D IHC (Heart, Kidney, Lung) | |||||||||
| CPT: Multiple | 40 | EA | ||||||||
| 0004 | Necropsy - Gross and Microscopic (Brain) | |||||||||
| CPT: 88027 | 5 | EA | ||||||||
| 0005 | Muscle/Nerve Biopsy with IHC and/or Teased Fiber Prep | |||||||||
| CPT: Multiple | 10 | EA | ||||||||
| 0006 | Initial Single Antibody Stain Procedure (immunosluorescence) | |||||||||
| CPT: 88346 | 30 | EA | ||||||||
| 0007 | Immunofluorescent study using a single antibody stain procedure – typically used in conjunction with CPT code 88346 | |||||||||
| CPT: 88350 | 120 | EA | ||||||||
| 0008 | Initial single antibody immunohistochemistry (IHC) stain (See Sub-Line Items for individual antibodies and cocktails) | |||||||||
| CPT: 88342, 88341 | 650 | EA | ||||||||
| 0008 | AA | Androgen Receptor (AR) | 0 | EA | ||||||
| 0008 | AB | Beta- Catenin | 0 | EA | ||||||
| 0008 | AC | Breast Cancer Panel (ER, PR,HER2, Ki-67) | 0 | EA | ||||||
| 0008 | AD | CD56 (NCAM) | 0 | EA | ||||||
| 0008 | AE | CD99 (MIC-2) | 0 | EA | ||||||
| 0008 | AF | CDX2 | 0 | EA | ||||||
| 0008 | AG | D2-40 | 0 | EA | ||||||
| 0008 | AH | DOG1 | 0 | EA | ||||||
| 0008 | AJ | E-Cadherin | 0 | EA | ||||||
| 0008 | AK | Estrogen Receptor (SP1) | 0 | EA | ||||||
| 0008 | AL | GATA-3 | 0 | EA | ||||||
| 0008 | AM | Glypican 3 | 0 | EA | ||||||
| 0008 | AN | Herpes 8 | 0 | EA | ||||||
| 0008 | AP | IgG | 0 | EA | ||||||
| 0008 | AQ | IgG4 | 0 | EA | ||||||
| 0008 | AR | Inhibin | 0 | EA | ||||||
| 0008 | AS | INSM-1 | 0 | EA | ||||||
| 0008 | AT | Ki-67 (MIB-1) | 0 | EA | ||||||
| 0008 | AU | Melanoma panel (HMB45, M2-7C10, M2-9E3) | 0 | EA | ||||||
| 0008 | AV | Mismatch Repair (MMR) (MLH1, MLH2, MSH6, PMS2) | 0 | EA | ||||||
| 0008 | AW | MOC-31 | 0 | EA | ||||||
| 0008 | AX | Myogenin | 0 | EA | ||||||
| 0008 | AY | Napsin A | 0 | EA | ||||||
| 0008 | AZ | NKX3.1 | 0 | EA | ||||||
| 0008 | BA | OCT 4 | 0 | EA | ||||||
| 0008 | BB | p16 (INK4) | 0 | EA | ||||||
| 0008 | BC | p40 | 0 | EA | ||||||
| 0008 | BD | p504A (AMCR) -Racemase | 0 | EA | ||||||
| 0008 | BE | p53 | 0 | EA | ||||||
| 0008 | BF | p63 | 0 | EA | ||||||
| 0008 | BG | Pax-2 | 0 | EA | ||||||
| 0008 | BH | Pax-8 | 0 | EA | ||||||
| 0008 | BJ | PIN-4 panel (AMACR, p63, HMWK) | 0 | EA | ||||||
| 0008 | BK | PLAP | 0 | EA | ||||||
| 0008 | BL | Progesterone receptor (PR) | 0 | EA | ||||||
| 0008 | BM | PTEN | 0 | EA | ||||||
| 0008 | BN | SALL4 | 0 | EA | ||||||
| 0008 | BP | SMAD-4 | 0 | EA | ||||||
| 0008 | BQ | Smooth Muscle Myosin (SMM) | 0 | EA | ||||||
| 0008 | BR | Smoothelin | 0 | EA | ||||||
| 0008 | BS | SOX10 | 0 | EA | ||||||
| 0008 | BT | Syphilis | 0 | EA | ||||||
| 0008 | BU | Tryptase | 0 | EA | ||||||
| 0008 | BV | Villin | 0 | EA | ||||||
| 0008 | BW | WT-1 (6F-H2) | 0 | EA | ||||||
| 0008 | BX | Additional single antibody stain procedure | 0 | EA | ||||||
| 0009 | Initial single probe stain procedure for insitu hybridization (ISH) *must inlcude EBV (EBER), KAPPA, LAMBDA, HPV | |||||||||
| CPT: 88365 | 15 | EA | ||||||||
| 0010 | Morphmetric Analysis of immunohistochemistry-stained slides * must include HER2 IHC stain, PD-L1 (Multiple Clones), Breast Cancer Panel (ER,PR,HER2 ,Ki-67) | |||||||||
| CPT: 88360 | 30 | EA | ||||||||
| 0011 | IHC with reflex to FISH studies must include HER2 | |||||||||
| CPT: 88360 | 15 | EA | ||||||||
| 0012 | Factor V Leiden | |||||||||
| CPT: 81241 | 110 | EA | ||||||||
| 0013 | Factor II Prothrombin Mutation | |||||||||
| CPT: 81240 | 60 | EA | ||||||||
| 0014 | PNH | |||||||||
| CPT: 88184, 88185, 88188 | 15 | EA | ||||||||
| 0015 | Flow Cytometry studies - blood, tissue, bone marrow, fluid | |||||||||
| CPT: Multiple | 80 | EA | ||||||||
| 0016 | Cytogenetics/Chromsome Analysis | |||||||||
| CPT: Multiple | 185 | EA | ||||||||
| 0017 | Fluorescence In-situ Hybridization | |||||||||
| CPT: Multiple | 285 | EA |
File details come from the government source that posted it. Updated .